Many locations

Multiple Locations

0 studies enrolling now · 7 studies all time

What they study most

Chronic Kidney Disease, Contraception, Hemophilia A, Liver Neoplasms, Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion, Prostate Cancer, Type 2 Diabetes Mellitus

Studies at this site

• Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body — Recruiting now
• A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described — Running, not enrolling
• Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A — Running, not enrolling
• A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting — Running, not enrolling
• Study to Learn More About the Physical Activity Level of Patients Suffering From Hemophilia A Treated With Damoctocog Alfa Pegol (LIFE ACTIVE Study) — Completed
• Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC) — Completed
• KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method — Completed